کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
1392982 | 1501167 | 2012 | 8 صفحه PDF | دانلود رایگان |
Based on some structural analogies with leflunomide and brequinar, two well-known inhibitors of dihydroorotate dehydrogenase (DHODH), a new series of products was designed, by joining the substituted biphenyl moiety to the 4-hydroxy-1,2,5-oxadiazol-3-yl scaffold through an amide bridge. The compounds were studied for their DHODH inhibitory activity on rat liver mitochondrial/microsomal membranes. The activity was found to be closely dependent on the substitution pattern at the biphenyl system; the most potent products were those bearing two or four fluorine atoms at the phenyl adjacent to the oxadiazole ring. A molecular modeling study suggested that these structures might have a brequinar-like binding mode. The greater potency of fluorinated analogs may depend partly on enhanced interactions with the hydrophobic ubiquinone channel, and partly on the role of fluorine in stabilizing the putative bioactive conformation.
Figure optionsDownload as PowerPoint slideHighlights
► The hydroxyfurazan ring system is a new scaffold yielding potent DHODH inhibitors.
► The new hydroxyfurazanyl derivatives seem to bind DHODH in a brequinar-like fashion.
► Fluorinated substituents enhance enzyme-inhibitor interactions.
► Aromatic fluorine stabilizes the putative bioactive conformation.
Journal: European Journal of Medicinal Chemistry - Volume 49, March 2012, Pages 102–109